top of page

The more information about how to reduce the risk of spread and the severity of sickness, the more lives that can be saved, and the more comfortable Americans will feel about starting to resume normal life.

Scott Gottlieb, MD

Former FDA Commissioner 

Wall Street Journal - May 18, 2020



Bill Faloon

Dates Drug Question More.png

I suffer from a genetic bone marrow deficit that places me in the high-risk category for developing severe COVID-19 disease if I were to be infected with the SARS/Cov-2 virus.

As reports emanated from New York City about crematories running 24-hours/day, I began all-night searches of the medical literature to ascertain if better treatments might already be available.


My sense of urgency is intensified by reports indicating that patients fortunate enough to survive ventilator support often suffer systemic organ damage.


As I uncovered bits of data and sent it to others in my network, some potential experimental treatments began to emerge that might save lives.


This website was established to open-source medical information that in normal times might be considered premature. But these are not normal times.

How to Use this Website


We began analyzing data for this website in early March 2020 and much of it was drafted into a lengthy, early narrative titled What Your Doctor May Consider if COVID-19 Symptoms Worsen.

As more information accumulated, we created an “Interventions” tab on the top that enables you to read about heparin, interferon-alpha, antibodies, remdesivir and cytokine suppressing drugs, most in the category of reducing excess IL-6 signaling. (All of these drugs should be administered in a medical setting).


We then created a Key Dangers tab to enlighten readers about some of the pathological mechanisms that are occurring in SARS/Cov-2 infected patients, especially in advanced stages of COVID-19 disease.


There is a Suggestions Box for those who may want to contribute additional non-commercial data about more effective ways to prevent or treat COVID-19 disease.


This can be accessed under the Connect With Us tab.


My INTRO tab has been slightly updated since it went to hard copy print.


The NEWS section will try to frequently emphasize important breakthroughs and key insights regarding Covid-19 that are appearing in various press releases, data sources and news networks moving forward.


Please know we are updating this non-commercial website when time permits.  


Information Dissemination and Discussion Groups


Given the rapid and evolving nature of medical/scientific data on COVID-19/ SARS-CoV-2, some or most of the information on this website may be rendered obsolete, or worse, incorrect at any future time. 

Much more validated data is likely to be discovered over the next 3-6 months. 


The reports contained herein are based largely on pre-publication reports and evidence from previous published studies.

If you contemplate initiating any of the suggestions discussed on this website, please remember that these are all still in experimental stages and not subject to rigorous clinical trial design, execution or peer review.


Data pertaining to experimental treatment options are disseminated for public education purposes. 


COVID-19 patients and their families may choose to share this information with treating physicians for experimental considerations.

bottom of page